We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
+$557M
(+1.4%)
Cap. Flow
+$599M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
791
New
88
Increased
233
Reduced
320
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$977M |
| 2 |
Lockheed Martin
LMT
|
+$187M |
| 3 |
Kimberly-Clark
KMB
|
+$149M |
| 4 |
CELG
Celgene Corp
CELG
|
+$142M |
| 5 |
Under Armour Class C
UA
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$781M |
| 2 |
RTN
Raytheon Company
RTN
|
+$186M |
| 3 |
Costco
COST
|
+$133M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.18% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Solid Biosciences
SLDB
$794M
| $5.09M | 0.01% |
+32,800
| New | +$3.71M |
|
|
FSTX
627
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.9M | 0.01% |
356,250
| – | – |
|
|
SMAR
628
DELISTED
Smartsheet Inc.
SMAR
| $4.86M | 0.01% |
+135,000
| New | +$6.43M |
|
629
Cathay General Bancorp
CATY
$4.22B
| $4.86M | 0.01% |
140,000
| – | – |
|
|
FPRX
630
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.84M | 0.01% |
1,250,000
+50,000
| +4% | +$274K |
|
631
Henry Schein
HSIC
$9.77B
| $4.77M | 0.01% |
75,100
+28,300
| +60% | +$1.83M |
|
632
TripAdvisor
TRIP
$1.65B
| $4.63M | 0.01% |
119,700
-1,200
| -1% | -$50K |
|
|
AIV
633
Aimco
AIV
$387M
| $4.44M | 0.01% |
639,497
-800,976
| -56% | -$5.42M |
|
|
GAP
634
The Gap Inc
GAP
$7.23B
| $4.43M | 0.01% |
255,466
-2,400
| -0.9% | -$42.6K |
|
635
Okta
OKTA
$24.7B
| $4.43M | 0.01% |
+45,000
| New | +$5.62M |
|
636
Visteon
VC
$2.79B
| $4.41M | 0.01% |
+53,400
| New | +$3.56M |
|
637
Liberty Energy
LBRT
$3.05B
| $4.33M | 0.01% |
400,000
-100,000
| -20% | -$1.23M |
|
638
Sundial Growers
SNDL
$320M
| $4.32M | 0.01% |
+90,000
| New | +$7.99M |
|
639
MongoDB
MDB
$27.1B
| $4.22M | 0.01% |
+35,000
| New | +$5.05M |
|
|
VAR
640
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.1M | 0.01% |
34,395
-1,000
| -3% | -$119K |
|
|
CALA
641
DELISTED
Calithera Biosciences, Inc
CALA
| $4.02M | 0.01% |
65,000
+5,000
| +8% | +$400K |
|
|
TWO
642
Two Harbors Investment
TWO
$1.27B
| $3.94M | 0.01% |
+75,000
| New | +$3.96M |
|
643
Alerus Financial
ALRS
$831M
| $3.92M | 0.01% |
+180,000
| New | +$3.94M |
|
|
AABA
644
DELISTED
Altaba Inc
AABA
| $3.9M | 0.01% |
+200,000
| New | +$13.2M |
|
645
Macerich
MAC
$7.33B
| $3.72M | 0.01% |
117,800
+61,406
| +109% | +$1.94M |
|
646
Expro Ltd
XPRO
$1.79B
| $3.71M | 0.01% |
130,141
| – | – |
|
647
Coty
COTY
$2.42B
| $3.71M | 0.01% |
352,844
-3,300
| -0.9% | -$34.2K |
|
648
Chewy
CHWY
$9.25B
| $3.69M | 0.01% |
150,000
| – | – |
|
|
NEWR
649
DELISTED
New Relic, Inc.
NEWR
| $3.69M | 0.01% |
+60,000
| New | +$4.34M |
|
|
WRK
650
DELISTED
WestRock Company
WRK
| $3.54M | 0.01% |
97,100
-213,189
| -69% | -$7.61M |
|
Similar funds
Adage Capital Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Adage Capital Partners held 791 positions worth $40.7B, up 1.4% from $40.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners's Q3 2019 filing shows 88 new, 233 increased, 320 reduced and 78 closed positions. Its largest new stake was Kimberly-Clark: 1,083,253 shares worth $154M. The largest sale was Anadarko Petroleum, an estimated $781M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Adage Capital Partners's largest Q3 2019 buy was Kimberly-Clark: 1,083,253 shares worth $154M.
- Adage Capital Partners added most to Allergan plc in Q3 2019, an estimated $977M increase.
- Adage Capital Partners's biggest Q3 2019 reduction was Costco, cutting an estimated $133M.
- Adage Capital Partners fully exited Anadarko Petroleum in Q3 2019, selling an estimated $781M.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q3 2019.
- Adage Capital Partners opened 88 new positions and closed 78 in Q3 2019.
- Adage Capital Partners's portfolio value rose 1.4% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.